www.cumberlandpharma.com
Open in
urlscan Pro
184.106.55.64
Public Scan
Submitted URL: http://cumberlandpharma.com/
Effective URL: https://www.cumberlandpharma.com/
Submission: On December 25 via api from US — Scanned from DE
Effective URL: https://www.cumberlandpharma.com/
Submission: On December 25 via api from US — Scanned from DE
Form analysis
1 forms found in the DOMPOST /
<form action="/" method="post" id="search-block-form" accept-charset="UTF-8">
<div>
<div class="container-inline">
<h2 class="element-invisible">Search form</h2>
<div class="form-item form-type-textfield form-item-search-block-form">
<label class="element-invisible" for="edit-search-block-form--2">Search </label>
<input title="Enter the terms you wish to search for." onblur="if (this.value == '') {this.value = 'Search';}" onfocus="if (this.value == 'Search') {this.value = '';}" type="text" id="edit-search-block-form--2" name="search_block_form"
value="Search" size="30" maxlength="128" class="form-text">
</div>
<div class="form-actions form-wrapper" id="edit-actions"><input type="submit" id="edit-submit" name="op" value="" class="form-submit"></div><input type="hidden" name="form_build_id" value="form-t1QAKkkGeGF5_6QqtSqXR5ZsqDenK972ykJDhb6ODqo">
<input type="hidden" name="form_id" value="search_block_form">
</div>
</div>
</form>
Text Content
SEARCH FORM Search * ABOUT US * PROFILE & MISSION * OUR STRATEGY * LEADERSHIP TEAM * COMPANY HISTORY * OUR PRODUCTS * CUMBERLAND EMERGING TECHNOLOGIES * INVESTOR RELATIONS * CORPORATE UPDATE * CORPORATE GOVERNANCE * Board of Directors * Management * Committees * Contact the Board * STOCK INFORMATION * Historic Stock Lookup * Analyst Coverage * Ownership Profile * FINANCIAL INFORMATION * SEC Fillings * Annual Reports * Quarterly Results * Key Ratios * EVENTS & PRESENTATIONS * INVESTOR FAQ'S * NEWS RELEASES * Press Releases * Corporate Updates * In the News * CONTACT IR * NEWS * BLOG * CONTACT US CORPORATE HEADQUARTERS Cumberland Pharmaceuticals Inc. 1600 West End Avenue, Suite 1300 Nashville, TN 37203 Phone: (615) 255-0068 Toll Free: (877) 484-2700 Fax: (615) 255-0094 info@cumberlandpharma.com *For directions to us, please see Location EMPLOYMENT OPPORTUNITIES employment@cumberlandpharma.com INVESTOR RELATIONS investors@cumberlandpharma.com BUSINESS DEVELOPMENT development@cumberlandpharma.com WHOLESALER CUSTOMER SERVICE Phone: (877) 274-7200 Fax: (614) 652-9127 MEDICAL INFORMATION This website is not for medical emergencies. If you are a patient, caregiver or healthcare professional and need product related information, please visit our Products page, which will link you to product-specific websites. ADVERSE EVENT REPORTING Toll Free Phone: (877) 484-2700 (For healthcare professionals only) IMPROVING CARE Cumberland Pharmaceuticals is on a mission to improve patient care through the delivery of high-quality pharmaceutical products. Learn More About Our Products QUALITY PRODUCTS Vibativ is an FDA-approved treatment for certain serious bacterial infections with proven efficacy against difficult-to-treat Gram-positive infections. Learn More About Our Products PROVIDING SOLUTIONS Caldolor is the first injectable approved in the U.S. to manage pain in adults and pediatric patients and has been shown to help reduce the need for opioids. Learn More About Our Products SUPPORTING PATIENTS Kristalose is the only prescription laxative product available in a powder formulation. Learn More About Our Products EXPANDING OUR PIPELINE With the addition of our Phase II candidate for patients with Duchenne muscular dystrophy, we are developing new medicines for the future. Learn More About Our Products CORPORATE SUSTAINABILITY We support our mission through community involvement, ethical marketing, drug safety policies and more. View Sustainability Report * 1 * 2 * 3 * 4 * 5 * 6 Learn more about recent company developments from Cumberland Pharmaceuticals’ Founder and Chief Executive Officer A.J. Kazimi. Read Message RECENT NEWS November 8, 2022 Cumberland Pharmaceuticals Reports 41% Revenue Growth November 1, 2022 CUMBERLAND PHARMACEUTICALS TO ANNOUNCE THIRD QUARTER 2022 FINANCIAL RESULTS View All CPIX (COMMON STOCK) Exchange: NASDAQ Open: 2.08 Price: 2.11 Change: -0.13 (5.59%) Volume: 1,904 Data as of Friday 12/23/2022 04:00 PM E.T. Minimum 20 minute delay ©Cumberland Pharmaceuticals Inc. 1600 West End Avenue, Suite 1300, Nashville, TN 37203 ... ESG ReportSite MapPrivacy PolicyTerms & ConditionsExpanded Patient Access Policy